首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Uptake Of Particulate Vaccine Adjuvants By Dendritic Cells Activates The Nalp3 Inflammasome
【24h】

Uptake Of Particulate Vaccine Adjuvants By Dendritic Cells Activates The Nalp3 Inflammasome

机译:树突状细胞摄取颗粒状疫苗佐剂会激活Nalp3炎症小体。

获取原文
获取原文并翻译 | 示例
       

摘要

Many currently used and candidate vaccine adjuvants are particulate in nature, but their mechanism of action is not well understood. Here, we show that particulate adjuvants, including biodegradable poly(lactide-co-glycolide) (PLG) and polystyrene microparticles, dramatically enhance secretion of interleukin-1β (IL-1β) by dendritic cells (DCs). The ability of particulates to promote IL-1β secretion and caspase 1 activation required particle uptake by DCs and NALP3. Uptake of microparticles induced lysosomal damage, whereas particle-mediated enhancement of IL-1β secretion required phagosomal acidification and the lysosomal cysteine protease cathepsin B, suggesting a role for lysosomal damage in inflammasome activation. Although the presence of a Toll-like receptor (TLR) agonist was required to induce IL-1β production in vitro, injection of the adjuvants in the absence of TLR agonists induced IL-1β production at the injection site, indicating that endogenous factors can synergize with particulates to promote inflammasome activation. The enhancement of antigen-specific antibody production by PLG microparticles was independent of NALP3. However, the ability of PLG microparticles to promote antigen-specific IL-6 production by T cells and the recruitment and activation of a population of CD11b~+Gr1~- cells required NALP3. Our data demonstrate that uptake of microparticulate adjuvants by DCs activates the NALP3 inflammasome, and this contributes to their enhancing effects on innate and antigen-specific cellular immunity.
机译:许多目前使用的候选疫苗佐剂本质上是颗粒状的,但对其作用机理尚不十分了解。在这里,我们显示了颗粒状佐剂,包括可生物降解的聚(丙交酯-共-乙交酯)(PLG)和聚苯乙烯微粒,可显着增强树突细胞(DC)分泌白介素1β(IL-1β)。颗粒促进IL-1β分泌和caspase 1活化的能力要求DC和NALP3吸收颗粒。微粒的摄取诱导了溶酶体损伤,而微粒介导的IL-1β分泌增强需要吞噬体酸化和溶酶体半胱氨酸蛋白酶组织蛋白酶B,提示溶酶体损伤在炎性体活化中起作用。尽管在体外需要诱导Toll样受体(TLR)激动剂来诱导IL-1β产生,但是在没有TLR激动剂的情况下注射佐剂会在注射部位诱导IL-1β的产生,这表明内源性因子可以协同作用。与微粒促进炎性体活化。 PLG微粒对抗原特异性抗体产生的增强作用独立于NALP3。但是,PLG微粒促进T细胞产生抗原特异性IL-6的能力以及CD11b〜+ Gr1〜-细胞群的募集和激活的能力需要NALP3。我们的数据表明DC摄取微粒佐剂会激活NALP3炎性小体,这有助于它们增强对先天和抗原特异性细胞免疫的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号